FAK-IN-29
FAK-IN-29 is a selective FAK inhibitor with an IC50 of 0.5 nM. FAK-IN-29 can inhibit the proliferation and colony formation of MDA-MB-231 cells, and induce cell cycle arrest and apoptosis. FAK-IN-29 exhibits antitumor activity and can be used for the research of tumors such as triple-negative breast cancer[1].
Product Specifications
CAS Number
[3104566-26-6]
UNSPSC
12352005
Target
Apoptosis; FAK
Related Pathways
Apoptosis; Protein Tyrosine Kinase/RTK
Field of Research
Cancer
Smiles
O=C(NC)C1=CC=CC=C1NC2=C3C(NC=C3F)=NC(NC4=CC=CC(CC(N5CCNCC5)=O)=C4)=N2
Molecular Formula
C26H27FN8O2
Molecular Weight
502.54
References & Citations
[1]Zhang D, et al. Structural optimization and biological evaluation of 5-fluoro-7H-pyrrolo[2,3- d]pyrimidine derivatives as potent FAK inhibitors for the treatment of triple negative breast cancers (TNBC) . Eur J Med Chem. 2026;302 (Pt 3) :118370.
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
MBS1475493-01 0.02 mg (E-Coli)
Recombinant Ralstonia solanacearum Exodeoxyribonuclease 7 small subunit (xseB)
Ask
View Details MBS1475493-02 0.1 mg (E-Coli)
Recombinant Ralstonia solanacearum Exodeoxyribonuclease 7 small subunit (xseB)
Ask
View Details MBS1475493-03 0.02 mg (Yeast)
Recombinant Ralstonia solanacearum Exodeoxyribonuclease 7 small subunit (xseB)
Ask
View Details 
MBS1475493-04 0.1 mg (Yeast)
Recombinant Ralstonia solanacearum Exodeoxyribonuclease 7 small subunit (xseB)
Ask
View Details MBS1475493-05 0.02 mg (Baculovirus)
Recombinant Ralstonia solanacearum Exodeoxyribonuclease 7 small subunit (xseB)
Ask
View Details 
MBS1475493-06 1 mg (E-Coli)
Recombinant Ralstonia solanacearum Exodeoxyribonuclease 7 small subunit (xseB)
Ask
View Details